Four cases of menorrhagia in von Willebrand disease were successfully
treated with tranexamic acid given in a single daily dose of 4 g for t
he first 3-5 days of the menstrual cycle. The pathophysiology and phar
macokinetics are discussed. The apparent improved efficacy and accepta
bility of this new dosing regime have been highlighted.